SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-048621
Filing Date
2021-09-23
Accepted
2021-09-22 17:42:17
Documents
13
Period of Report
2021-09-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abcl-8k_20210921.htm   iXBRL 8-K 45806
2 EX-99.1 abcl-ex991_24.htm EX-99.1 21063
  Complete submission text file 0001564590-21-048621.txt   201890

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA abcl-20210921.xsd EX-101.SCH 5689
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE abcl-20210921_lab.xml EX-101.LAB 19323
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abcl-20210921_pre.xml EX-101.PRE 11486
6 EXTRACTED XBRL INSTANCE DOCUMENT abcl-8k_20210921_htm.xml XML 3518
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39781 | Film No.: 211270403
SIC: 2834 Pharmaceutical Preparations